.png)
Opening a Demat account is the first step for any Indian investor. But situations often arise where one might want to close or transfer their account. Whether you are shifting to a new broker, consolidating holdings, or simply exiting the markets, understanding the right SEBI-compliant process ensures your money and securities remain safe.
This guide explains the step-by-step process of closing or transferring your Demat account in India, with practical insights for retail investors.
While brokers like Zerodha, Groww, Upstox, Angel One, and ICICI Direct are popular, Swastika Investmart stands out for its:
Q1. Can I close my Demat account online?
Some brokers allow partial digital closure, but most require a physical signed form as per SEBI rules.
Q2. How long does it take to close a Demat account?
Typically 7–10 working days, depending on pending verifications.
Q3. Can I keep multiple Demat accounts?
Yes, SEBI allows multiple Demat accounts under the same PAN with different brokers.
Q4. What happens if I don’t use my Demat account?
Inactive accounts may attract AMC charges. It’s better to close unused accounts.
Q5. What happens if I don’t use my Demat account?
Inactive accounts may attract AMC charges. It’s better to close unused accounts.
Closing or transferring a Demat account in India is straightforward if you follow SEBI’s prescribed steps. Always clear dues, verify holdings, and ensure paperwork is submitted correctly.
For beginners and seasoned investors alike, choosing a reliable broker makes all the difference. With its strong regional support, advisory services, and SEBI-compliant systems, Swastika Investmart ensures your Demat journey is smooth from start to finish.
👉 Ready to experience hassle-free investing?
Open your Demat Account with Swastika Investmart
📱 Download the Swastika App:
Global Health Limited is one of the major private multi-specialty tertiary care providers in India's North and East. Cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology are among the company's major specialties.
Global Health Limited now operates four hospitals under the "Medanta" name (Gurugram, Indore, Ranchi, and Lucknow). The Medanta Institutional Tissue Repository was created in 2017 to encourage biomarker and other tissue-based research.
IPO DateNov 3, 2022 to Nov 7, 2022Listing Date[.]Face Value₹2 per sharePrice₹319 to ₹336 per shareLot Size44 SharesIssue Size[.] shares of ₹2(aggregating up to ₹2,205.57 Cr)Fresh Issue[.] shares of ₹2(aggregating up to ₹500.00 Cr)Offer for Sale50,761,000 shares of ₹2(aggregating up to ₹1,705.57 Cr)Issue TypeBook Built Issue IPOListing AtBSE, NSEQIB Shares OfferedNot more than 50% of the OfferNII (HNI) Shares OfferedNot less than 15% of the OfferRetail Shares OfferedNot less than 35% of the OfferCompany PromotersDr. Naresh Trehan is the company promoter.
The IPO of Global Health Limited, a company that operates and manages hospitals under the Medanta brand, is scheduled to open for subscription on November 3. According to the Red Herring Prospectus (RHP), investors can invest in this IPO till November 7. According to merchant banking sources, the size of the IPO could be around Rs 2,200 crore. Under the IPO, fresh equity shares of Rs 500 crore will be issued. In addition, 5.08 crore equity shares will be sold by the promoters of the company under offer-for-sale (OFS).
As a part of the OFS, Anant Investments, private equity major Carlyle Group and Sunil Sachdeva (jointly with Suman Sachdeva) will sell the shares. At present, Anant Investments holds a 25.64 percent stake in Global Health and Sachdeva holds 13.41 percent in the company. The funds received under this IPO will be used for the repayment of loans and for general corporate purposes.
The net proceeds of the new issuance will be used to repay debt, finance capital expenditure, fund the future acquisition of subsidiary Bio needs India, fund working capital requirements, and for general corporate purposes.
Over the fiscal years 2017-22, the Indian healthcare delivery industry is expected to develop at a 10-12% CAGR to a value of roughly Rs. 5 lakh crore. Furthermore, with strong sector macros such as lower hospital bed density in relation to population, lower expenditure on healthcare infrastructure as compared to developed and several developing countries, rising income levels & increasing affordability for healthcare services, and the government's Ayushman Bharat scheme, the healthcare delivery market is expected to grow at a 13-14% CAGR over FY22-26E to reach Rs. 8.3 lakh cr.
With long-term structural factors supporting growth, renewed impetus from PMJAY, and the government's focus shifting onto the healthcare sector, the healthcare delivery market is expected to grow at 13–15%. GHL is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India and operating under the most popular healthcare brand Medanta. It has generated strong revenue growth in the last 3 years, with a minor setback in FY21. Coming to the offer, the major proportion in this issue is the offer for sale, which could be a limiting factor in this issue. The promoter shareholding would come down to 33% post-IPO, which is another concern; nevertheless, the issuer has good patient volumes and cost efficiency, and its financial profile also shows an increasing trend. Finally, the issue is fairly priced at a P/E of 43 as compared to the average industry P/E of 51.93. Thus, we recommend a Subscribe rating for the long term.
According to IPO Watch, the grey market premium (GMP) for the Global Health IPO is now rs 25 per share. This suggests that the stock will most likely be offered at 361, a 7.44% premium to the IPO price.
The company's shares will be distributed to winning bidders on November 11, and refunds will be issued on November 14. Shares will be credited to the successful bidders' Demat accounts by 15 November, and the stock will begin trading on the stock markets on 16 November.
Bikaji Foods International Limited is a leading fast-moving consumer goods ("FMCG") brand in India. The product range consists of six major categories: bhujia, namkeen, packaged sweets, papad, western snacks, and other snacks, which principally comprise gift packs (assortment), frozen food, mathri range, and cookies. They sold over 250 items under the Bikaji brand in the six months ending September 30, 2021. Shiv Ratan Agarwal, Deepak Agarwal, Shiv Ratan Agarwal (HUF), and Deepak Agarwal are the company's promoters (HUF). The category allocation for qualifying institutional buyers is 50.0%, 15.0% for non-individual investors or high net worth individuals, and 35.0% for retail investors.
Opening Date03, November 2022Closing Date07, November 2022Refund Initiation14, November 2022Listing Date16, November 2022Face Value₹1 per equity share IPO Price Band₹285 to ₹300 per equity share Minimum Order Quantity50 Shares Issue Size₹881.22 Cr
On Thursday, Bikaji Foods launched an initial public offering (IPO) to obtain funds up to Rs 881 crore. The IPO Bikaji is purely an offer for sale (OFS) by existing shareholders, which means the company would get no proceeds from the transaction. Fresh shares will not be issued in this.
For three trading days till November 7, Bikaji Foods shares will be available for bidding between 10 a.m. and 5 p.m. The IPO consists of an offer for sale (OFS) of approximately 2.94 crore equity shares by promoters and existing shareholders. Bikaji Foods raised 262.11 crores from 36 anchor investors ahead of its IPO on November 2.
Bikaji Foods said in a BSE filing that it has finalized the allocation of 87.37 lakh equity shares to anchor investors after consulting with merchant bankers. These shares were offered to anchor investors for $300 each.
Receive the advantages of listing equity shares on stock exchanges.
Bikaji expects the listing to enhance company exposure and brand image while also offering a public market for equity shares in India.
Bikaji's revenue from operations grew 22.90% to Rs. 1610.96 crore for fiscal 2022 against Rs. 1310.75 crore for fiscal 2021, primarily due to increase in the sale of food products, and an increase in volume and realization of products, in particular, bhujia, Namkeen, papad, western snacks, and packaged sweets, while its net profits stood at Rs 76.03 crore in FY22. For the three months ending June 30, 2022, revenue from operations stood at Rs 419.16 crore and net profit was Rs 15.70 crore.
Due to shifting lifestyles, rising incomes, and urbanization, India's packaged food industry has experienced tremendous growth over the past five years. Currently, pan-Indian demand for regional snacks is booming. Bikaji is a popular brand in this segment and is among the top three Indian ethnic snack manufacturers in India with a pan-India presence. The company has a strong management team and a significant percentage of promoter holdings. It generated strong revenue growth in the last 3 years where revenue improved from Rs. 1082.9 crores in FY2020 to Rs. 1621.45 crores in FY2022. However, the company's margins are on the declining side and a P/E valuation of 95.2 looks expensive. Finally, this issue is a complete offer for sale, and thus we recommend a Subscribe rating, but only for high-risk investors.
The company will finalize the IPO share allotment on November 11 and refunds will be credited to the bank accounts of unsuccessful investors by November 11. The IPO shares will be transferred to Demat accounts of eligible investors by November 14. Bikaji Foods will make its debut on the BSE and National Stock Exchange on November 16.
.png)
Credit Suisse, one of the oldest and most significant banksin the world, has experienced substantial challenges recently. As of mid-2024,the bank's share price has significantly declined, with a drop of around 70%since the beginning of 2023. Over the last three quarters, Credit Suisse hasreported losses amounting to approximately 5 billion Swiss francs ($5.6billion), and its borrowing costs have increased due to multiple ratingdowngrades. The cost of insuring its debt has also soared to the highest levelin 16 years, surpassing levels seen during the 2008 global financial crisis.
Credit Suisse is under increased scrutiny due to a series oflosses, poor risk management, and changes in its senior leadership.
Over the past two years, Credit Suisse has faced numerouscrises and continues to strategize for recovery. The bank made $2 billion inthe first nine months of 2023, a 52% decrease from the same period in theprevious year. The new strategy likely involves further cutting back itsinvestment bank, which has caused problems, including significant losses fromthe collapse of Archegos Capital.
The bank has made several poor decisions in recent years. Itencouraged clients to invest $10 billion, leading to significant losses whenGreensill went bankrupt. This has increased the cost of borrowing for CreditSuisse and severely impacted its financial health.
Credit Suisse is facing higher borrowing costs, which isstraining its finances further.
The bank has had many leadership changes since 2020. CEOTidjane Thiam resigned in 2020 due to a spying scandal. His successor, ThomasGottstein, was CEO until July 2022, when restructuring expert Ulrich Koernertook over. These changes have raised investor concerns and added to the bank'sinstability.
Credit Suisse plans to expand its wealth managementbusiness, transform its investment bank into a "capital-light, advisory-led"business, and review options for its Securitized Products division. It may needto raise between 4-6 billion Swiss francs to reorganize and sustain growth.This could come from selling assets or issuing new shares, which might dilutecurrent shares. Another option is to seek a significant investor for a tailoredcapital raise or, as a last resort, apply for public aid.
Credit Suisse has a market cap of around $8 billion andmanages $1.4 trillion in assets as of the end of Q2 2024. Its shares havedeclined by 65% over the past year. The bank operates in wealth management,investment banking, and asset management. It has reported around $5 billion inlosses and faces higher borrowing costs due to rating downgrades. In India,Credit Suisse has Rs 19,500 crore on its balance sheet as of the end of FY23.
Any new strategic plan might fail. Widening credit spreadscould increase market anxiety, lower confidence among business partners, andtemporarily raise financing costs. Over time, the decline in share price willmake it harder for Credit Suisse to raise money and reorganize its investmentbanking operations. Even in the worst-case scenario, any fallout from apossible Credit Suisse collapse would likely only have a temporary effect onIndia's financial markets, with little impact on Indian banks.
अमेरिकी मुद्रास्फीति के कम होने से निवेशकों में उम्मीद बढ़ गई है कि फेडरल रिजर्व आने वाले महीनों में ब्याज दरों में बढ़ोतरी की गति को कम कर देगा क्योकि मुद्रास्फीति अब नियंत्रित होती दिखाई दे रही है। ब्याज दरों में वृद्धि की गति धीमे होने की उम्मीद में सोने की कीमतें पिछले सप्ताह में ढाई महीने के उच्च स्तर पर पहुंच गई और पिछले कुछ महीनों में पिछला सप्ताह कीमती धातुओं के लिए सबसे अच्छा रहा, जिसमे घरेलु वायदा बाजार में सोना 3 प्रतिशत तेज़ हो कर 52500 रुपये प्रति दस ग्राम और चांदी भी 3 प्रतिशत तेज़ हो कर 62500 रुपये प्रति किलो के स्तरों पर पहुंच गई है। अमेरिकी मुद्रास्फीति ( सीपीआई) अक्टूबर में पिछले नौ महीनों में सबसे धीमी गति पर रही। अक्टूबर के लिए हाल ही में जारी अमेरिकी उपभोक्ता मूल्य सूचकांक (सीपीआई) रिपोर्ट 7.9 प्रतिशत के अनुमान की तुलना में 7.7 प्रतिशत साल-दर-साल रही, जो सितंबर की रिपोर्ट में 8.2 प्रतिशत थी। मुद्रास्फीति की यह रिपोर्ट अमेरिकी फेड के आक्रामक निर्णय को बदल सकती है जिसका असर बाजार में देखने को मिल रहा है। बाज़ार में फेड द्वारा ब्याज दरें 75 आधार अंक बढ़ाने की जगह 50 आधार अंक बढ़ाने की अटकले तेज़ हो गई है। अमेरिकी डॉलर, जो सोने के विपरीत दिशा में चलता है, लगभग तीन महीनों के निचले स्तरों पर पहुंच गया है, जबकि 10 साल की अमेरिकी ट्रेजरी यील्ड 4 प्रतिशत के नीचे फिसल गई है, जो एक महीने का निचला स्तर है। भारत में शादी सीजन शुरू होने से कीमती धातुओं की हाज़िर मांग अभी मजबूत रहने की सम्भावना है। सोने के विकल्प के रूप में मानी जाने वाली क्रिप्टो करेंसी बिटकॉइन अपने उच्चतम स्तरों से 75 प्रतिशत टूट चुकी है, जिससे निवेशकों का भरोसा सोने में बना हुआ है।
इस सप्ताह कीमती धातुओं में तेज़ी जारी रहने की सम्भावना है। दिसम्बर वायदा सोने की कीमतों में 51400 रुपये पर सपोर्ट है और 53200 रुपये पर प्रतिरोध है। दिसंबर वायदा चांदी में 61000 रुपये पर सपोर्ट और 63500 रुपये पर प्रतिरोध है।
तीसरी तिमाही में अमेरिका के जीडीपी आंकड़े अनुमान से मजबूत दर्ज किये गए जिससे पिछले सप्ताह डॉलर इंडेक्स में तेज़ी रही और कीमती धातुओं में बिकवाली का दबाव रहा। अमेरिका से जारी आकड़ो से संकेत मिलते है की ब्याज दरों में वृद्धि के बावजूद अमेरिकी अर्थव्यवस्था बेहतर प्रदर्शन कर रही है। अर्थव्यवस्था में लचीलेपन के संकेत से फेडरल रिजर्व को तेज़ गति से ब्याज दरों को बढ़ाने के लिए अधिक जगह मिली हैं। इससे डॉलर और ट्रेजरी यील्ड को बढ़ावा मिला है और कीमती धातुओं पर दबाव बढ़ा है। मजबूत जीडीपी डेटा ने ऐसी उम्मीदों को कम कर दिया कि केंद्रीय बैंक दिसंबर में ब्याज दरों में बढ़ोतरी की गति को धीमा कर देगा। अमेरिकी केंद्रीय बैंक द्वारा व्यापक रूप से अगले सप्ताह ब्याज दरों में 75 आधार अंकों की वृद्धि की उम्मीद है, जो इस साल चौथी ब्याज दर वृद्धि होगी। यूरो का उपयोग करने वाले 19 देशों के लिए केंद्रीय बैंक (ईसीबी) ने अपनी मैन रीफिनान्सिंग दर को 75 आधार अंकों से बढ़ाकर 2 प्रतिशत कर दिया, जो 2009 के बाद से उच्चतम दर है। पिछले सप्ताह एमसीएक्स में सोना 0.35 प्रतिशत टूट कर 50450 रुपए प्रति दस ग्राम के स्तरों पर रहा जबकि चांदी की कीमते सपाट रही और 57700 रुपए प्रति किलो पर कारोबार करती रही।
इस सप्ताह अमेरिकी फ़ेडरल बैंक की बैठक और पैरोल के आंकड़े कीमती धातुओं के लिए महत्वपूर्ण रहेंगे। और कीमतों में दबाव रहने की सम्भावना है। दिसम्बर वायदा सोने की कीमतों में 49700 रुपये पर सपोर्ट है और 51000 रुपये पर प्रतिरोध है। दिसंबर वायदा चांदी में 55000 रुपये पर सपोर्ट और 59000 रुपये पर प्रतिरोध है।
फेड की ब्याज दरों को लेकर आक्रामक मौद्रिक नीति के रहते अमेरिकी बेंचमार्क ट्रेज़री यील्ड 4.2 प्रतिशत के स्तरों पर पहुंच चुकी है, जो 15 साल का उच्चतम स्तर है। ट्रेज़री यील्ड में तेज़ी रहने से अमेरिकी डॉलर, जो सोने के विपरीत दिशा में चलता है, लगातार 20 सालों की उचाई पर मंडरा रहा है। मजबूत अमेरिकी बांड यील्ड और डॉलर के सामने सोने की कीमतों में गिरावट बनी हुई है और कॉमेक्स वायदा बाजार में सोने के भाव 1630 डॉलर प्रति औंस के निचे फिसल चुके है, जो दो सालों का निचला स्तर है। घरेलु वायदा बाजार में भी सोने की कीमतों में गिरावट आई है, लेकिन रुपय का डॉलर की तुलना में कमजोर रहने से यह गिरावट सीमित बनी हुई है। अमेरिकी डॉलर 82.50 रुपये के स्तरों पर पहुंच चुका है। दुनिया भर में बढ़ती ब्याज दरों ने सोना रखने की अवसर लागत को बढ़ा दिया है। सोने पर आउटलुक इस उम्मीद से मंद है कि केंद्रीय बैंक मुद्रास्फीति के खिलाफ अपनी लड़ाई में ब्याज दरें बढ़ाना जारी रखेंगे। बाजार में उम्मीद हैं कि फेड नवंबर में दरों में 75 आधार अंकों की वृद्धि करेगा। केंद्रीय बैंक के सदस्यों ने भी हाल ही में चेतावनी दी है कि अगर मुद्रास्फीति समय पर नियंत्रित नहीं हुई तो ब्याज दरें उम्मीद से कहीं ज्यादा बढ़ सकती हैं।
इस सप्ताह दिवाली पर बाज़ारो में अवकाश रहने से सोने की मांग सुस्त रह सकती है जिससे कीमतों में गिरावट रहने की सम्भावना है। दिसम्बर वायदा सोने की कीमतों में 49000 रुपये पर सपोर्ट है और 50800 रुपये पर प्रतिरोध है। दिसंबर वायदा चांदी में 53000 रुपये पर सपोर्ट और 57000 रुपये पर प्रतिरोध है।
Trust Our Expert Picks
for Your Investments!
.webp)
.png)
.png)
